Fetal complication of thyrotoxicosis
- Fetal tachycardia,
- Intrauterine growth retardation,
- Prematurity, stillbirth
- Congenital malformations
Fetal complication of over treatment with ATD
- Hypothyroidism→ poor brain development
- Goiter
- Drug treatment
Newly diagnosed hyperthyroidism during pregnancy (gestational thyrotoxicosis)
- B-adrenoceptor antagonists (B-blockers) in the short term
- Antithyroid drugs:
- Propylthiouracil (PTU) is the preferred antithyroid drug
- Carbimazole: during the first trimester →choanal atresia and aplasia cutis.
Hyperthyroid women who become pregnant
- Continue current drug (carbimazole or PTU) in pregnancy, with close monitoring.
**To avoid fetal hypothyroidism, it is important to use the smallest dose of antithyroid drug (typically < 150 mg PTU or 15 mg carbimazole per day) that will maintain maternal free T4, T3 and TSH concentrations within their respective reference ranges.
First trimester | From beginning of 2nd trimester | Breast feeding: |
Propylthiouracil | Carbimazole | Propylthiouracil |
- Thyroid Surgery
- Poor drug adherence
- Drug hypersensitivity
- Failure of medical treatment / large dose
- Safely performed during the Second trimester.
- Preparation: Beta blocker, short course of KI
- Radioiodine therapy
- Absolutely contraindicated in pregnancy → invariably induce fetal hypothyroidism
** Frequent review of mother and fetus (monitoring heart rate and growth) is important during pregnancy and in the puerperium.
** Serum TRAb levels can be measured in the Third trimester to predict the likelihood of neonatal thyrotoxicosis.
ATD during lactation
- PTU is the drug of choice in the breastfeeding mother, as it is excreted in the milk to a much lesser extent than carbimazole.
- Should be administered following a feeding and in divided doses
- Thyroid function should be monitored periodically in the breastfed child.
SAQ. A 24 year old woman with 8 weeks of pregnancy presented with palpitation, weight loss, and sweating. Lab reports showed TSH <0.01 mIU/L, FT4-42 nmol/L.
- Mention 2 differentials for this condition?
- Gestational transient thyrotoxicosis
- Graves’ disease
- What immediate investigation would you suggest?
- TSH receptor antibody (TRab)
- What is your management plan for this lady?
During pregnancy
- First trimester: B blocker, propylthiouracil <150 ug/day, (carbimazole 15 mg/day if ongoing)
- 2nd trimester: Continue the current medications, thyroid surgery if needed
- 3rd trimester: Monitoring TRab, if not elevated discontinue before 4 weeks of EDD.
During Delivery
- In hospital in presence of an endocrinologist and obstetrician.
- Mode of delivery as per obstetrician suggests.
Breast feeding:
- Propylthiouracil,
- Monitoring of LFT.